LYON, France — A 72-year-old woman with dry age-related macular degeneration (AMD) was the first patient to receive an artificial retina implant as part of the multicenter PRIMAvera clinical trial, which is looking at the safety and efficacy of the PRIMA system. “Her vision was severely impaired by this condition. We used the ETDRS chart to assess her visual acuity,...
